Paris, France

Angelique Godet

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angelique Godet. Retrieved from https://idiyas.com/inventor/angelique-godet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angelique Godet: Innovator in Pro-Apoptotic Peptides

Introduction: Angelique Godet is a prominent inventor based in Paris, France, known for her groundbreaking work in the field of biotechnology. With her innovative contributions, she aims to enhance therapeutic approaches for cancer treatment through her unique inventions.

Latest Patents: Angelique holds a patent for a significant invention titled "Pro-apoptotic peptides." This inventive work focuses on chimeric peptides that serve as pro-apoptotic agents, promoting the inhibition of in vitro cell proliferation, which is crucial for the treatment of tumors.

Career Highlights: Throughout her career, Angelique has demonstrated her commitment to advancing medical science. Her pioneering research has not only added to her expertise but has also positioned her as a valuable contributor to the field of cancer therapy.

Collaborations: Angelique collaborates with esteemed colleagues in her endeavors, including Angelita Rebollo Garcia and Alphonse Garcia. Together, they work towards pushing the boundaries of scientific knowledge and fostering innovative solutions in their respective areas.

Conclusion: With her innovative spirit and dedication to research, Angelique Godet is making significant strides in the development of therapeutic agents. Her work exemplifies the potential of scientific invention to revolutionize treatment modalities and improve patient outcomes in the battle against tumors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…